Clinical variable | LTLE group (n = 23) | RTLE group (n = 30) | p-value |
---|---|---|---|
Type of seizure | NA | ||
CPS | 21 | 28 | - |
CPS + sGTC | 2 | 2 | - |
Duration of epilepsy (years) | 12.28 ± 6.38 | 10.68 ± 6.34 | 0.37 |
Seizure frequency (months) | 6.83 ± 7.51 | 5.87 ± 7.35 | 0.64 |
Engel class | 0.36 | ||
Class I | 21 | 27 | - |
Class II | 2 | 3 | - |
AED taken* | NA | ||
Levetiracetam | 3 | 6 | - |
Valproate | 9 | 13 | - |
Carbamazepine | 14 | 30 | - |
Clobazam | 10 | 5 | - |
Phenytoin | 4 | 6 | - |
Lamotrigine | 6 | 8 | - |
Phenobarbital | 1 | 3 | - |
Topiramate | 3 | 3 | - |
Number of AEDs | 2.26 ± 0.45 | 2.50 ± 0.51 | 0.55 |
EEG ictal onsets | NA | ||
Anterior temporal | 20 | 25 | - |
Anterior and mid temporal | 3 | 5 | - |
Values are presented as frequencies or means ± standard errors. Categorical data were analyzed using a χ2 test, and continuous data were analyzed using a 2-sample t-test.
Variable | Visit (months) | LTLE (n = 23) | RTLE (n = 30) | p-value* | LMTS (n = 16) | RMTS (n = 23) | p-value† |
---|---|---|---|---|---|---|---|
ΔHR during deep breathing test | |||||||
0 | 32.33 ± 1.94 | 18.86 ± 1.55 | < 0.001 | 32.70 ± 2.58 | 18.00 ± 1.94 | < 0.001 | |
3 | 22.40 ± 2.01 | 21.24 ± 1.46 | 0.64 | 23.38 ± 2.60 | 22.34 ± 1.81 | 0.74 | |
6 | 23.08 ± 2.95 | 21.17 ± 2.25 | 0.61 | 24.38 ± 3.76 | 20.95 ± 2.82 | 0.47 | |
p-value‡ | |||||||
0 vs. 3 | < 0.001 | 0.40 | 0.02 | 0.13 | |||
0 vs. 6 | 0.01 | 0.59 | 0.11 | 0.57 | |||
E:I ratio during deep breathing test | |||||||
0 | 1.44 ± 0.03 | 1.28 ± 0.02 | < 0.001 | 1.48 ± 0.03 | 1.30 ± 0.03 | < 0.001 | |
3 | 1.29 ± 0.05 | 1.32 ± 0.04 | 0.75 | 1.32 ± 0.06 | 1.34 ± 0.05 | 0.81 | |
6 | 1.30 ± 0.05 | 1.29 ± 0.04 | 0.85 | 1.31 ± 0.06 | 1.28 ± 0.05 | 0.79 | |
p-value‡ | |||||||
0 vs. 3 | 0.04 | 0.75 | 0.07 | 0.76 | |||
0 vs. 6 | 0.09 | 0.99 | 0.08 | 0.96 | |||
VR during Valsalva maneuver | |||||||
0 | 1.98 ± 0.13 | 1.83 ± 0.09 | NA§ | 1.98 ± 0.15 | 1.89 ± 0.12 | NA§ | |
3 | 1.74 ± 0.14 | 1.56 ± 0.10 | NA§ | 1.74 ± 0.18 | 1.56 ± 0.13 | NA§ | |
6 | 1.78 ± 0.12 | 1.69 ± 0.09 | NA§ | 1.78 ± 0.13 | 1.77 ± 0.10 | NA§ | |
p-value‡ | |||||||
0 vs. 3 | NA§ | NA§ | NA§ | NA§ | |||
0 vs. 6 | NA§ | NA§ | NA§ | NA§ | |||
30:15 ratio during head-up tilt test | |||||||
0 | 1.12 ± 0.02 | 1.13 ± 0.02 | NA§ | 1.16 ± 0.03 | 1.13 ± 0.02 | NA§ | |
3 | 1.10 ± 0.04 | 1.19 ± 0.03 | NA§ | 1.09 ± 0.04 | 1.16 ± 0.03 | NA§ | |
6 | 1.14 ± 0.03 | 1.11 ± 0.02 | NA§ | 1.14 ± 0.03 | 1.11 ± 0.03 | NA§ | |
p-value‡ | |||||||
0 vs. 3 | NA§ | NA§ | 0.52 | NA§ | |||
0 vs. 6 | NA§ | NA§ | 0.95 | NA§ |
All data except the p-values are presented as mean ± standard errors. Visit 0 was before surgery; visits 3 and 6 were 3 and 6 months after the surgery, respectively.
LTLE, left temporal lobe epilepsy; RTLE, right temporal lobe epilepsy; LMTS, left mesial temporal lobe sclerosis; RMTS, right mesial temporal lobe sclerosis; ΔHR, change in heart rate; E:I ratio, expiratory:inspiratory ratio during the deep breathing test; VR, Valsalva ratio; NA, not applicable; 30:15 ratio, ratio of the longest RR interval (around the 30th beat) to the shortest RR interval (around the 15th beat) on the ECG tracing after the 70º tilt during the head-up tilt test.
* Comparison of LTLE vs. RTLE. p-values obtained from random effects model using the GLIMMIX procedure in SAS with time as a repeated factor;
Variable | Visit (months) | LTLE (n = 23) | RTLE (n = 30) | p-value* | LMTS (n = 16) | RMTS (n = 23) | p-value† |
---|---|---|---|---|---|---|---|
ΔDBP during hand grip test | |||||||
0 | 19.31 ± 1.91 | 19.26 ± 1.52 | NA‡ | 20.11 ± 2.45 | 19.58 ± 1.86 | NA‡ | |
3 | 20.69 ± 2.81 | 19.00 ± 2.17 | NA‡ | 20.67 ± 3.69 | 18.70 ± 2.69 | NA‡ | |
6 | 25.34 ± 3.25 | 19.59 ± 2.47 | NA‡ | 24.92 ± 4.06 | 19.59 ± 3.08 | NA‡ | |
p-value | |||||||
0 vs. 3 | NA‡ | NA‡ | NA‡ | NA‡ | |||
0 vs. 6 | NA‡ | NA‡ | NA‡ | NA‡ | |||
ΔDBP during cold pressor test | |||||||
0 | 16.12 ± 2.18 | 18.61 ± 1.72 | 0.38 | 16.93 ± 2.80 | 19.34 ± 2.15 | 0.50 | |
3 | 15.00 ± 3.58 | 23.52 ± 2.83 | 0.07 | 13.62 ± 4.68 | 24.35 ± 3.41 | 0.07 | |
6 | 19.38 ± 2.67 | 8.59 ± 1.93 | 0.002 | 22.37 ± 2.96 | 9.52 ± 2.09 | 0.002 | |
p-value§ | |||||||
0 vs. 3 | 0.96 | 0.25 | 0.80 | 0.37 | |||
0 vs. 6 | 0.64 | 0.001 | 0.45 | 0.02 | |||
Fall in systolic BP during head-up tilt test | |||||||
0 | 8.67 ± 1.46 | 2.67 ± 1.19 | 0.002 | 10.46 ± 1.83† | 3.60 ± 1.48 | 0.008 | |
3 | 12.98 ± 2.93 | 6.49 ± 2.20 | 0.15 | 15.69 ± 3.67 | 5.32 ± 2.58 | 0.06 | |
6 | 8.89 ± 2.51 | 6.65 ± 1.90 | 0.22 | 5.80 ± 3.07 | 6.74 ± 2.31 | 0.61 | |
p-value|| | |||||||
0 vs. 3 | NS¶ | NS¶ | NS¶ | NS¶ | |||
0 vs. 6 | NS¶ | NS¶ | NS¶ | NS¶ |
All data except the p-values are presented as mean ± standard errors. Visit 0 was before surgery; visits 3 and 6 were 3 and 6 months after the surgery, respectively.
LTLE, left temporal lobe epilepsy; RTLE, right temporal lobe epilepsy; LMTS, left mesial temporal lobe sclerosis; RMTS, right temporal lobe sclerosis; ΔDBP, maximum increase in diastolic blood pressure; NA, not applicable; BP, blood pressure; NS, not significant.
* Comparison of LTLE vs. RTLE. p-values obtained from random effects model using the GLIMMIX procedure in SAS with time as a repeated factor;
† Comparison of LMTS vs. RMTS. p-values obtained from random effects model using the GLIMMIX procedure in SAS with time as a repeated factor;
‡ Because the group × time interaction did not show a significant difference and additional testing was not necessary;